F845-0385 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide

F845-0385 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide
F845-0385 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F845-0385
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F845-0385

Molecular Formula

C23H21N3O6S2 (C23 H21 N3 O6 S2)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-[3-(4-ethoxyphenyl)-124-oxadiazol-5-yl]-N-methylthiophene-3-sulfonamide

SMILES

CCOc(cc1)ccc1-c1noc(-c(scc2)c2S(N(C)c(cc2)cc3c2OCCO3)(=O)=O)n1

InChI

InChI=1S/C23H21N3O6S2/c1-3-29-17-7-4-15(5-8-17)22-24-23(32-25-22)21-20(10-13-33-21)34(27,28)26(2)16-6-9-18-19(14-16)31-12-11-30-18/h4-10,13-14H,3,11-12H2,1-2H3

InChI Key

YRJJWIHOHBBWCY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27199370

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.542

Distribution Coefficient, logD

4.542

Water Solubility, LogSw

-4.36

Polar Surface Area

88.431

Acid Dissociation Constant (pKa)

29.30

Base Dissociation Constant (pKb)

-4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

F845-0385 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F845-0385 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F845-0385?
Check Price and Availability of F845-0385, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F845-0385 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F845-0385
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F845-0385
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F845-0385 available by request